Iyo kambani yakambozivisa muna Gumiguru 20, 2021 kubata kwekiriniki kwakaiswa pachidzidzo neFDA. Kambani yakazivisa nezvenyaya iyi muna Mbudzi 18, 2021 uye yakatumira shanduko kuFDA yechikumbiro cheInvestigational New Drug (IND) musi wa9 Zvita 2021. Kuburikidza nechiziviso chakagamuchirwa svondo rino, FDA yakabvisa chipatara ichi ndokupa zano. Tryp kuti rienderere mberi nekudzidza.
Vachitaura nezvebudiriro iyi, Sachigaro uye CEO Greg McKee vakati, “Tinofara kuenderera mberi nechikamu chedu 2a chekiriniki yekuyedza kusagadzikana kwekudya zvakanyanya kuburikidza nekudyidzana kwedu neYunivhesiti yeFlorida. Nhaurirano yedu neFDA yave nekubudirira uye yakavandudza zvine mutsindo magadzirirwo echidzidzo ichi. Izvi zvinomiririra chidzidzo chechipiri chekiriniki muna 2021 chatakawana mvumo kubva kuFDA kuti titange.
ZVOKUBVA MUNYAYA INO:
- Iyo Kambani yakapa tsvakiridzo panhau iyi munaNovember 18, 2021 uye yakatumira shanduko kuFDA yechikumbiro cheInvestigational New Drug (IND) muna Zvita 9, 2021.
- Kuburikidza nechiziviso chakatambirwa svondo rino, FDA yakabvisa kiriniki yakabata uye yakayambira Tryp kuti inogona kuenderera mberi nechidzidzo.
- Vachitaura nezvebudiriro iyi, Sachigaro uye CEO Greg McKee vakati, “Tinofara kuenderera mberi nechikamu chedu 2a chekiriniki yekuedza kusagadzikana kwekudya zvakanyanya kuburikidza nekudyidzana kwedu neYunivhesiti yeFlorida.
